DEGRO practical guidelines for radiotherapy of breast cancer II: Postmastectomy radiotherapy, irradiation of regional lymphatics, and treatment of locally advanced disease

Strahlentherapie und Onkologie

Volumn 184, Issue 7, 2008, Pages 347-353

  Sautter Bihl, Marie Luise ^a,k   Souchon, Rainer ^b   Budach, Wilfried ^c   Sedlmayer, Felix ^d   Feyer, Petra ^e   Harms, Wolfgang ^f   Haase, Wulf ^g   Dunst, Jürgen ^h   Wenz, Frederik ⁱ   Sauer, Rolf ^j  

^a Municipal Hospital Karlsruhe   (Germany)

^b Allgemeines Krankenhaus Hagen gem GmbH   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d Salzburger Landeskliniken   (Austria)

^e VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^f St Claraspital AG   (Switzerland)

^g St Vincentius Kliniken   (Germany)

^h UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

ⁱ UNIVERSITY OF HEIDELBERG   (Germany)

^j UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^k STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

more..

Author keywords

Locally advanced disease; Lymph node irradiation; Postmastectomy radiotherapy; Radiotherapy of breast cancer; Sequencing of local and systemic treatment

Indexed keywords

ADVANCED CANCER; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RECURRENCE; CANCER SURVIVAL; CONSENSUS; EVIDENCE BASED MEDICINE; HUMAN; LYMPHATIC SYSTEM; MASTECTOMY; MEDICAL DECISION MAKING; MEDICAL SOCIETY; POSTOPERATIVE CARE; PRACTICE GUIDELINE; RADIATION DOSE; REVIEW;

AGE FACTORS; AGED; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; LYMPHATIC IRRADIATION; LYMPHATIC METASTASIS; MASTECTOMY; NEOPLASM STAGING; RADIOTHERAPY; RADIOTHERAPY, ADJUVANT;

EID: 56549119882     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-008-1901-8     Document Type: Review

References (56)

1. Ahn PH, Vu HT, Lannin D, et al. Sequence of radiotherapy with tamoxifen in conservatively managed breast cancer does not affect local relapse rates. J Clin Oncol 2005;23:17-23.
2. Anderson WF, Chu KC, Chang S. Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities? J Clin Oncol 2003;21:2254-9.
3. Belkacemi Y, Gligorov, Ozsahin M, et al. Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric study. Ann Oncol 2008;19:1110-6.
4. Bellon J, Come S, Gelman RS. Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial. J Clin Oncol 2005;23:1934-40.
5. Buchholz T, Haffty B. Breast cancer: locally advanced and recurrent disease, postmastectomy radiation, and systemic therapies. In: Perez CA, Brady LW, Halperin EC, eds. Principles and practice of radiation oncology. Philadelphia: Lippincott Williams & Wilkins, 2008:1292-317.
6. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;366:2087-106.
7. Cristofanilli M, Singletary ES, Hortobagyi GN. Inflammatory breast carcinoma: the sphinx of breast cancer research. J Clin Oncol 2004;22:381-3.
8. Deutsche Krebsgesellschaft e.V. Interdisziplinäre S3-Leitlinien für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms. München: Zuckschwerdt, 2008:74-81 (http://www.senologie.org/leitlinien. htm).
9. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 2000;355:1757-70.
10. EBMG. Evidence-based medicine guidelines 2006. Helsinki, Finland: Duodecim Medical Publications LTD, 2006.
11. Gebski V, Lagleva M, Keech A, et al. Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective. J Natl Cancer Inst 2006;98:26-38.
12. Gruber G, Menzi S, Forster A, et al. Sites of failure in breast cancer patients with extracapsular invasion of lymph node metastases. No need for axillary irradiation? Strahlenther Onkol 2005;181:574-9.
13. Halyard MY, Pisanski TM, Solin LJ, et al. Adjuvant radiotherapy and trastuzumab in stage I-IIA breast cancer: toxicity data from North Central Cancer Treatment Group Phase II trial N 9831. Clin Oncol (R Coll Radiol) 2006;24:18 S (Suppl.) 523 (abstr).
14. Harris HE, Christensen VJ, Hwang WT, et al. Impact of concurrent versus sequential tamoxifen with radiation therapy in early stage breast cancer patients undergoing breast conservation treatment. J Clin Oncol 2005;23:11-6.
15. Hellman S. Stopping metastases at their source. N Engl J Med 1997;337:996-7.
16. Hickey BE, Francis D, Lehmann MH. Sequencing of chemotherapy and radiation therapy for early breast cancer. Cochrane Database Syst Rev 2006;4:CD005212.
17. Hoeller U, Borgmann K, Feyer P, et al. Zur Interaktion von Strahlentherapie und Tamoxifen beim Mammakarzinom. Strahlenther Onkol 2007;183:535-44.
18. Huang EH, Strom EA, Perkins GH, et al. Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score. Int J Radiat Oncol Biol Phys 2006;66:352-7.
19. Huang EH, Tucker SL, Strom EA, et al. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. J Clin Oncol 2004;22:4691-9.
20. Huang J, Barbera L, Brouwers M, et al. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 2003;21:555-63.
21. Kaufmann M, Minckwitz G von, Smith R, et al. International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations. J Clin Oncol 2003;21:2600-8.
22. Louis-Sylvestre C, Clough K, Asselain B, et al. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. J Clin Oncol 2004;22:97-101.
23. Marks LB, Zeng J, Prosnitz LR. One to three versus four or more positive nodes and postmastectomy radiotherapy: time to end the debate. J Clin Oncol 2008;26:2075-7.
24. McGuire SE, Gonzalez-Angulo AM, Huang EH, et al. Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys 2007;68:1004-9.
25. Mignano JE, Zahurak ML, Chakravarthy A, et al. Significance of axillary nodal soft tissue extension and indications for postmastectomy irradiation. Cancer 1999;86:1258-62.
26. NCCN, National Comprehensive Cancer Network. Clinical practice guidelines in oncology: breast cancer - version V.1.2007. NCCN, 2007.
27. NCCN, National Comprehensive Cancer Network. Clinical practice guidelines in oncology: breast cancer - version V.2.2008. NCCN, 2008.
28. NHMRC, National Health and Medical Research Council of Australia. Management of early breast cancer. Clinical practice guidelines, 2001.
29. NHMRC, National Health and Medical Research Council of Australia. NBCC clinical practice guidelines for the management and support of younger women with breast cancer. Camperdown: National Breast Cancer Centre, 2003.
30. NHS. NHS Quality improvement Scotland. Breast cancer services: national overview. Edinburgh: NHSQIS, 2003.
31. Overgaard M, Nielsen HM, Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol 2007;82:247-53.
32. Peto R. Highlights from the 2005/6 EBCTCG worldwide overview of every women in all the trials in early breast cancer. Abstract book, 29th Annual San Antonio Breast Cancer Symposium, December 14-17, 2006. abstract 40.
33. Poortmans P, Kouloulias V, van Tienhoven G, et al. Quality assurance in the EORTC randomized trial 22922/10925 investigating the role of irradiation of the internal mammary and medial supraclavicular lymph node chain works. Strahlenther Onkol 2006;182:576-82.
34. Ragaz J, Olivotto IA, Spinelli JJ, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 2005;97:116-26.
35. Recht A, Edge SB, Solin LJ, et al. for the American Society of Clinical Oncology. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001;19:1539-69.
36. Ring A, Webb A, Ashley S, et al. Is surgery necessary after complete clinical remission following neoadjuvant chemotherapy for early breast cancer? J Clin Oncol 2003;21:4540-5.
37. Romond EH, Perez EA, Bryant J, et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 2005;353:1673-84.
38. Sauer R, on behalf of the Breast Cancer Expert Group of the German Society of Radiooncology (DEGRO). Guidelines for radiotherapy in breast cancer. Strahlenther Oncol 2006;182:Suppl I:1-28.
39. Sautter-Bihl ML, Budach W, Dunst J, et al. DEGRO practical guidelines for radiotherapy of breast cancer I. Breast-conserving therapy. Strahlenther Onkol 2007;183:661-6.
40. Shafiq J, Delaney G, Barton MB. An evidence-based estimation of local control and survival benefit of radiotherapy for breast cancer. Radiother Oncol 2007;84:11-7.
41. Shenkier T, Weir L, Levine M, et al. Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer. CMAJ 2004;170:983-94.
42. SIGN. Scottish Intercollegiate Guidelines Network. SIGN 84: Management of breast cancer in women. Scottish Intercollegiate Guidelines Network, 2005.
43. Singeltary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002;20:3628-36.
44. Smith BD, Haffty BG, Hurria A, et al. Postmastectomy radiation and survival in older women with breast cancer. J Clin Oncol 2006;24:4901-7.
45. Stranzl H, Ofner P, Peintinger F, et al. Postoperative irradiation in breast cancer patients with one to three positive axillary lymph nodes. Is there an impact of axillary extranodal tumor extension on locoregional and distant control? Strahlenther Onkol 2006;182:583-8.
46. Truong PT, Lee J, Kader HA, et al. Locoregional recurrence risks in elderly breast cancer patients treated with mastectomy without adjuvant radiotherapy. Eur J Cancer 2005;41:1267-77.
47. Truong PT, Olivotto IA, Kader HA, et al. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high post-mastectomy locoregional recurrence risk for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 2005;61:1337-47.
48. Truong PT, Olivotto IA, Whelan TJ, et al. Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. CMAJ 2004;170:1263-73.
49. UICC. Sobin LH, Wittekind CH, eds. TNM classification of malignant tumours, 6th edn. New York: Wiley-Liss, 2002.
50. Van de Steene J, Soete G, Storme G. Adjuvant radiotherapy for breast cancer significantly improves overall survival: the missing link. Radiother Oncol 2000;55:263-72.
51. Van de Steene J, Vinh-Hung V, Cutuli B, et al. Adjuvant radiotherapy for breast cancer: effects of longer follow-up. Radiother Oncol 2004;72:35-43.
52. Veronesi U, Galimberti V, Mariani L, et al. Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Eur J Cancer 2005;41:231-7.
53. Veronesi U, Orecchia R, Zurrida S, et al. Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy. Ann Oncol 2005;16:383-8.
54. Wallgren A, Bonetti M, Gelber RD, et al. International Breast Cancer Study Group Trials I through VII. Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII. J Clin Oncol 2003;21:1205-13.
55. Wapnir IL, Anderson SJ, Mamounas EP, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol 2006;24:2028-37.
56. Whelan T, Darby S, Taylor C, et al. Overviews of randomized trials of radiotherapy in early breast cancer. ASCO Annual Meeting Educational Book, 43rd Annual Meeting ASCO. 2007:3-6.